Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury

Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury
复制标题

DOI:
10.1634/stemcells.2006-0223
复制
发表时间:
2007-01-01
期刊:
影响因子:
5.2
通讯作者:
Sakata, Yoichi
Sakata, Yoichi
中科院分区:
医学2区
文献类型:
--
作者:
Kimura, Atsushi;Ohmori, Tsukasa;Sakata, Yoichi

文献摘要

被引文献

相似文献

神经干/祖细胞(NSPCs)迁移到中枢神经系统(CNS)的受损区域,以限制和/或修复损伤。尽管NSPCs的这种迁移特性在理论上可以用于CNS疾病的基于细胞的治疗,但对NSPCs迁移反应的机制知之甚少。在此,我们发现1-磷酸鞘氨醇(Sph-1-P),一种生理溶血磷脂介质,对NSPCs具有强的化学引诱活性,其中,Sph-1-P受体中,S1 P(1)大量表达。用百日咳毒素、Y-27632(Rho激酶抑制剂)和VPC 23019(S1 P(1)和S1 P(3)的竞争性抑制剂)预处理可抑制Sph-1-P诱导的NSPC迁移。Sph-1-P不作为细胞内介质或以自分泌方式起作用,因为掺入NSPCs的[H-3]鞘氨醇主要在细胞内转化为神经酰胺和鞘磷脂,并且未观察到Sph-1-P的刺激依赖性形成和细胞外释放。此外,脊髓中的Sph-1-P浓度在挫伤后7天显著增加,这是由于损伤区域中小胶质细胞和反应性星形胶质细胞的积累。这种局部增加的Sph 1-P浓度有助于体内移植的NSPCs通过其受体S1 P的迁移(1),因为用短发夹RNA干扰S1 P的慢病毒转导NSPCs(1)消除了体内NSPC向损伤区域的迁移。这是第一个报告,以确定在NSPC迁移到中枢神经系统的病理区域的脂质介质的生理作用,并进一步表明,Sph-1-P/S1 P(1)途径可能具有治疗潜力的中枢神经系统损伤。
Neural stem/progenitor cells (NSPCs) migrate toward a damaged area of the central nervous system (CNS) for the purpose of limiting and/or repairing the damage. Although this migratory property of NSPCs could theoretically be exploited for cell-based therapeutics of CNS diseases, little is known of the mechanisms responsible for migratory responses of NSPCs. Here, we found that sphingosine 1-phosphate (Sph-1-P), a physiological lysophospholipid mediator, had a potent chemoattractant activity for NSPCs, in which, of Sph-1-P receptors, S1P(1) was abundantly expressed. Sph-1-P-induced NSPC migration was inhibited by the pretreatment with pertussis toxin, Y-27632 (a Rho kinase inhibitor), and VPC23019 (a competitive inhibitor of S1P(1) and S1P(3)). Sph-1-P does not act as intracellular mediator or in an autocrine manner, because [H-3] sphingosine, incorporated into NSPCs, was mainly converted to ceramide and sphingomyeline intracellularly, and the stimulation-dependent formation and extracellular release of Sph-1-P were not observed. Further, Sph-1-P concentration in the spinal cord was significantly increased at 7 days after a contusion injury, due to accumulation of microglia and reactive astrocytes in the injured area. This locally increased Sph1-P concentration contributed to the migration of in vivo transplanted NSPCs through its receptor S1P(1), given that lentiviral transduction of NSPCs with a short hairpin RNA interference for S1P(1) abolished in vivo NSPC migration toward the injured area. This is the first report to identify a physiological role for a lipid mediator in NSPC migration toward a pathological area of the CNS and further indicates that the Sph-1-P/S1P(1) pathway may have therapeutic potential for CNS injuries.